Real-World Patient Perceptions of GLP-1 RAs and SGLT-2is with Cardiorenal Benefits

被引：0
|
作者：
Lambert, Natalie
Clark, Callahan
McCoy, Rozalina G.
Wong, Alyssa
Cook, David J.
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-618-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
618-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk
    Bailey, Clifford J.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02): : 97 - 99
  • [2] Hepatoprotective Benefits of SGLT-2 Inhibitors and GLP-1 Analogs
    Rajagopal, Divya
    Al Rashid, Sulthan
    JOURNAL OF DIABETOLOGY, 2024, 15 (04) : 458 - 459
  • [3] Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
    Edwards, Khary
    Li, Xilong
    Lingvay, Ildiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04): : 920 - 930
  • [4] Noninvasive monitoring of liver fat during treatment with GLP-1 analogues and SGLT-2 inhibitors in a real-world setting
    Mittag-Roussou, Vasiliki
    Wagenpfeil, Stefan
    Lammert, Frank
    Stokes, Caroline S.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (03)
  • [5] Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists
    Chen, Jia-Jin
    Lee, Tao-Han
    Yang, Huang-Yu
    KIDNEY INTERNATIONAL, 2024, 105 (03) : 442 - 444
  • [6] Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
    Sara Piccini
    Giuseppe Favacchio
    Cristina Panico
    Emanuela Morenghi
    Franco Folli
    Gherardo Mazziotti
    Andrea Gerardo Lania
    Marco Mirani
    Cardiovascular Diabetology, 22
  • [7] Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
    Piccini, Sara
    Favacchio, Giuseppe
    Panico, Cristina
    Morenghi, Emanuela
    Folli, Franco
    Mazziotti, Gherardo
    Lania, Andrea Gerardo
    Mirani, Marco
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [8] SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
    Matthew Anson
    Sizheng S. Zhao
    Philip Austin
    Gema H. Ibarburu
    Rayaz A. Malik
    Uazman Alam
    Diabetologia, 2023, 66 : 1869 - 1881
  • [9] SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
    Anson, Matthew
    Zhao, Sizheng S.
    Austin, Philip
    Ibarburu, Gema H.
    Malik, Rayaz A.
    Alam, Uazman
    DIABETOLOGIA, 2023, 66 (10) : 1869 - 1881
  • [10] Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin
    Lawrence Blonde
    Denis Raccah
    Elisheva Lew
    Juliana Meyers
    Elena Nikonova
    Mayank Ajmera
    Keith L. Davis
    Monica Bertolini
    Bruno Guerci
    Diabetes Therapy, 2018, 9 : 1169 - 1184
12345